SHELLAC
Unresolved Excipient
Suggest One
No specific molecular structure known for this excipient.
- CAS
- 9000593
- UNII
- 46N107B71O
- SYNONYMS
-
- ZINC ID(s)
-
- Availability
- Present in 0 ZINC catalogs
Known Active Genes
There has not been any activity reported at 10μM or less for this excipient (per ChEBML)
Clinical Trials
This compound has not been in (or located in) any clinical trials (per clinicaltrials.gov).
(Browse) Purchasable Analogs in ZINC
Analogs cannot be located as there is no structure provided for this compound. Try a
search by name.
Dosages
| Route | Formulation | Per Unit Dose |
|---|---|---|
| Oral | Capsule | 34.48MG |
| Oral | Capsule | 24.83MG |
| Oral | Capsule, Coated Pellets | 0.43MG |
| Oral | Capsule, Delayed Action, Enteric Coated | |
| Oral | Capsule, Enteric Coated Pellets | 29MG |
| Oral | Capsule, Extended Release | 0.07MG |
| Oral | Capsule, Soft Gelatin | |
| Oral | Capsule, Sustained Action | 31.2MG |
| Oral | Capsule, Sustained Action | 75.01MG |
| Oral | Capsule, Sustained Action | 60MG |
| Oral | Tablet | 18MG |
| Oral | Tablet | 24.04MG |
| Oral | Tablet, Coated | 3.4MG |
| Oral | Tablet, Coated | 15.2MG |
| Oral | Tablet, Delayed Action, Enteric Coated | 21.44MG |
| Oral | Tablet, Delayed Action, Enteric Coated | 3.31MG |
| Oral | Tablet, Extended Release | 1.24MG |
| Oral | Tablet, Film Coated | 0.74MG |
| Oral | Tablet, Film Coated | 4.4MG |
| Oral | Tablet, Sustained Action | 213.24MG |
| Oral | Tablet, Sustained Action | 7.3MG |
| Oral | Tablet, Sustained Action, Coated |